GILOTRIF (afatinib) Patient Assistance Program
Don’t let the high cost of targeted lung cancer therapy stand between you and the treatment you need. We help eligible patients access Gilotrif (afatinib) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Gilotrif (afatinib) is FDA-approved for the first-line treatment of metastatic non-small cell lung cancer (NSCLC) with non-resistant EGFR mutations, and for the treatment of advanced squamous cell NSCLC after progression on platinum-based chemotherapy.
- Without assistance, the retail cost commonly runs $11,700–$12,500 per month, totaling roughly $140,000–$150,000 per year if treatment continues continuously.
- Through AffordMyPrescriptions, qualifying patients can access Gilotrif for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic version of Gilotrif available in the U.S. as of 2026.
What Is Gilotrif Prescription Assistance Program?
The Gilotrif Prescription Assistance Program is a manufacturer-sponsored initiative that provides Gilotrif at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for uninsured and underinsured individuals, as well as Medicare Part D beneficiaries who cannot afford their targeted oncology therapy.
Navigating the program on your own means dealing with eligibility verification, oncology-team coordination, EGFR molecular testing documentation, specialty pharmacy logistics, and renewal deadlines — all while managing advanced lung cancer treatment.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your treatment, not paperwork.
Pharmacy Price Comparison
- Without assistance, Gilotrif costs roughly $11,700–$12,500 per month at retail pharmacies. Discount coupons offer little relief at this price level. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$12,400.00 | Save ~$12,330/mo |
| CVS Pharmacy | ~$12,500.00 | Save ~$12,430/mo |
| Walmart | ~$11,900.00 | Save ~$11,830/mo |
| Costco | ~$11,750.00 | Save ~$11,680/mo |
Kroger | ~$11,800.00 | Save ~$11,730/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.*
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Gilotrif Prescription Program?
The Patient Assistance Program is free to apply for and provides Gilotrif at no medication cost if approved. But the process involves detailed applications, oncology-team coordination, EGFR mutation documentation, specialty pharmacy logistics, and ongoing renewal management. Our $69.95/month service covers full advocacy: applications, doctor coordination, molecular-testing documentation, refill management, and annual re-enrollment — so you focus on your treatment, not paperwork.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Gilotrif:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Cards expire and require constant renewal
- Still $11,700–$12,500 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly from the manufacturer
- We manage all paperwork, refills, and renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Gilotrif assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Gilotrif Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Gilotrif:
Gilotrif (afatinib) is an oral, targeted oncology medicine used to treat advanced non-small cell lung cancer (NSCLC). It belongs to a class of medicines called tyrosine kinase inhibitors and is taken once daily as a single tablet. Eligibility for first-line use depends on a confirmed non-resistant EGFR mutation identified through FDA-approved molecular testing of the tumor.
How It Works:
Gilotrif functions by irreversibly attaching to the EGFR receptor family, which is often overactive in lung cancers with specific mutations. By blocking these receptors, the drug prevents cancer cells from receiving the constant signals that drive them to grow and divide. This targeted action effectively slows down the progression of the disease.
Form and Use:
The typical dosage is a 40 mg oral tablet taken once daily on an empty stomach, specifically one hour before or two hours after eating. For individuals with severe kidney issues, the starting dose is reduced to 30 mg. Your oncology team will monitor your progress and may adjust the dosage to help manage side effects.
Generic Availability:
As of 2026, there is no FDA-approved generic version of Gilotrif available in the U.S. due to active patent protections. While generic alternatives exist for other similar drugs like erlotinib, any switch to a different therapy depends on your specific mutation and medical history. Decisions regarding alternatives should be made exclusively by your oncology team.
Warnings:
The most frequent side effects include diarrhea, skin rashes or acne, and mouth inflammation, which can often be managed through dose adjustments. More serious but less common risks include liver toxicity, gastrointestinal perforation, and lung or skin reactions. Your medical team will provide continuous monitoring to ensure these risks are managed safely.
FAQ (Frequently Asked Questions)
How Much Does Gilotrif Cost Without Insurance?
The retail price for a 30-day supply at the standard 40 mg dose commonly runs $11,700–$12,500 per month. Coupon discounts at major pharmacies exist but are modest because the underlying price is so high. Through AffordMyPrescriptions, qualifying patients receive Gilotrif at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is The EGFR Mutation Confirmed?
An EGFR mutation is confirmed through molecular testing of the tumor, often a next-generation sequencing panel performed on a biopsy or surgical specimen. Gilotrif is approved for first-line use in metastatic NSCLC only when the tumor has been confirmed to carry a non-resistant EGFR mutation.
Are There Other EGFR Inhibitors I Should Know About?
Yes. Erlotinib (which has generic options) and newer third-generation agents such as osimertinib are also used in EGFR-mutated NSCLC. Whether any of them is a clinical fit for you depends on the specific EGFR mutation, your prior treatment, and other factors. We mention this directly because if a different therapy on a more accessible assistance pathway would work for your situation, that may be a better path than paying for our advocacy on Gilotrif specifically.
Can I Get Gilotrif Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify for Gilotrif Patient Assistance, especially if you face specialty-tier copays you cannot afford. The manufacturer’s commercial copay savings program ($0 per fill, up to ~$5,500/month and ~$25,000/year) is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If your initial application is denied, we explore alternative savings paths on your behalf — including independent oncology-focused foundations such as the PAN Foundation, HealthWell Foundation, or lung-cancer-specific organizations like GO2 for Lung Cancer, the manufacturer’s copay savings program if you have commercial insurance, or asking your oncology team whether a different EGFR-targeted therapy would be a clinical option for you. If we cannot find a path to medication access, you will not be charged our service fee.
How Long Does It Take To Get Approved?
Most enrolled patients receive their first Gilotrif shipment within two to four weeks of completing the documentation. Timing depends on how quickly your oncology team returns the required forms and the program processes your application.
Take Control of Your Medication Costs
If you are struggling with the high cost of Gilotrif, our team may be able to help you access assistance programs designed to make targeted lung cancer therapy affordable. Check your eligibility today and take the first step toward predictable, sustainable treatment.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.